Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2005
08/17/2005EP1499594B1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
08/17/2005EP1463725B1 Process and intermediates for pyridazinone antidiabetic agents
08/17/2005EP1343761B1 Piperidine mch antagonists and their use in the treatment of obesity
08/17/2005EP1282418B1 Use of pyrazole derivatives for treating infertility
08/17/2005EP1266887B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
08/17/2005EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/17/2005CN1656091A Tetrahydropyran derivatives
08/17/2005CN1656087A Therapeutic ion channel blocking agents and methods of use thereof
08/17/2005CN1656086A Benzofuran derivative
08/17/2005CN1656082A Protein kinase inhibitors
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656078A Aminoindazole derivatives as protein kinase inhibitor
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/17/2005CN1656071A New piperidine derivative
08/17/2005CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
08/17/2005CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase
08/17/2005CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/17/2005CN1215060C Condensed pyrazole compound, composition containing it and its application
08/17/2005CN1215059C Novel heterocyclic compounds and salts thereof and medicinal use of same
08/17/2005CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives
08/16/2005US6930188 Stable hydrate of a muscarinic receptor antagonist
08/16/2005US6930186 Process for the preparation of paroxetine substantially free of alkoxy impurities
08/16/2005US6930136 For use on metal substrates or in adhesive, sealant or coating compositions for use in proximity to metal substrates
08/16/2005US6930117 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
08/16/2005US6930110 Nitrogen compounds such as 5-chloro-4-{4-[4-(2,3-dihydrobenzo[1,4]dioxine-5-yl)-piperazine-1-yl]-butylamino}-2H-piridazin-3-one, used as anxiolytic and hypotensive agents; side effect reduction
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/16/2005US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives
08/16/2005US6930102 16-halogen-epothilone derivatives, process for their production, and their pharmaceutical use
08/16/2005CA2342974C Methods and compositions for inhibition of angiogenesis
08/16/2005CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them
08/16/2005CA2238521C Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
08/11/2005WO2005073224A2 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005WO2005073222A1 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity
08/11/2005WO2005073219A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073210A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these
08/11/2005WO2005073196A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073189A1 Fused heteroyral derivatives for use as p38 kinase inhibitors
08/11/2005WO2005072733A1 Dyarylurea compounds as chk-1 inhibitors
08/11/2005WO2005072681A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
08/11/2005WO2005072082A2 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
08/11/2005WO2005053663A3 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
08/11/2005WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2005000233A3 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2005US20050176967 Alkylating 4-amino-1,2,4-triazole with a stearically hindered methyl oxirane; chemical intermediates, fungicidal compositions for cereal diseases
08/11/2005US20050176964 Nicotinamide derivatives useful as p38 inhibitors
08/11/2005US20050176958 Rhodium and iridium complexes
08/11/2005US20050176948 Libraries; locked nucleic acids; peptide nucleic acids
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid
08/11/2005US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis
08/11/2005US20050176780 2,5-disubstituted 3-mercaptopentanoic acid
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176772 Melanocortin MCR4 agonists; treating female sexual dysfunction, male erectile dysfunction, obesity or diabetes; e.g. [1-tert-Butyl-4-(2,4-difluoro-phenyl)-pyrrolidin-3-yl]-(4-hydroxy-3,5-dimethyl-4-phenyl-piperidin-1-yl)-methanone or its hydrochloride
08/11/2005US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity
08/11/2005US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
08/11/2005US20050176767 Pyridine carboxamide and methods for inhibiting HIV integrase
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/11/2005US20050176764 Medicine for treating cancer
08/11/2005US20050176763 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
08/11/2005US20050176733 Chk-1 inhibitors
08/11/2005US20050176726 Pyrimidine ether derivatives; antiinflammatory; analgesic; antiarthritis; antirheumatic;diseases involving sensory nerve function; 2-((6-(4-((1S)-1-(4-fluorophenyl)ethyl)-1-piperazinyl)-4-pyrimidinyl)oxy)quinoline
08/11/2005US20050176724 2-Methyl-5-(2-{4-[3-(1-methylpiperidin-4-yl)benzyl]piperidin-1-yl}ethoxy)quinoline hydrochloride; antagonist of 5-serotonin (HT)1 type receptors;antidepressant and anxiolytic agent
08/11/2005US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines
08/11/2005US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis
08/11/2005US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
08/11/2005US20050176712 Integrin expression inhibitor
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof
08/11/2005US20050175856 Electroluminescent device
08/11/2005CA2553968A1 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
08/11/2005CA2553433A1 Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005CA2553084A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1560824A1 Compounds useful as inhibitors of jak and other protein kinases
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1560817A1 Methods and compositions of novel triazine compounds
08/10/2005EP1560816A1 Quinazoline derivatives
08/10/2005EP1560815A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
08/10/2005EP1560811A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP0848710B1 2,4- diamino-1,3,5-triazines, process for the production thereof, and the use thereof as herbicides and plant growth regulators
08/10/2005CN1653125A Amelioration of the development of cataracts and other ophthalmic diseases
08/10/2005CN1653078A Method for synthesizing beta-L-fluoro-2', 3'-dideoxy-didehydrocytidine (beta-L-FD4C)
08/10/2005CN1653063A (S)-4-amino-5-chloro-2-methoxy-N-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, and method for producing the same, pharmaceutical composition containing the same and i
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653056A Dihydoxyhexanoic acid derivatives, their intermediates, and methods of making
08/10/2005CN1653053A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
08/10/2005CN1653048A Pyridine carboxamide derivatives and their use as pesticides
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 694